Mashhadiabbas Fatemeh, Rajabi Moones, KharaziFard Mohammad Javad, Moslemi Hamidreza
Dental Research Center, Research Institute of Dental School, Dept. of Oral and maxillofacial Pathology, School of Dentistry, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Oral and Maxillofacial Pathologist, Tehran, Iran.
J Dent (Shiraz). 2018 Dec;19(4):287-294.
Oral squamous cell carcinoma (OSCC) is one of the most widely occurring cancers worldwide. Early diagnosis of primary tumors is the key to improve treatment outcome. Detecting cancer, determining prognosis, and monitoring disease progression or treatment response can be done based on molecular markers. CA19-9 is an isolated form of Lewis antigen. It is widely used for detecting pancreatic cancer in the clinical setting. P57 (KiP2) is a tumor suppressor gene. It is a positive regulator of cell proliferation, regulating proliferation through G1 phase by inhibiting cyclin dependent kinases. Its expression decreases in most malignancies. OSCC has variable differentiation grades and local invasion potential.
The aim of this study was to evaluate and assess the correlation of CA19-9 and P57 expression with invasive front and grade of OSCC.
This cross-sectional study was performed on forty paraffin blocks in three histologic grades; well, moderate, and poorly differentiated SCC. The two markers were assessed by immunohistochemistry methods (En vision). Proportional and total scores and staining intensity were measured for all samples.
CA19-9 staining was low in all three grades. The Kruskal Wallis test showed no significant correlation between tumor grade and CA19-9 expression; however, there was a significant difference between tumor intensity and margin intensity (= 0.003). P57 staining was high in all three grades. The Kruskal Wallis test showed no significant correlation between tumor grade and P57 expression. There were no significant differences in total intensity of staining in margins of tumor (= 0.85).
Within the limitations of this study, it may be concluded that expression of CA19-9 and P57 cannot be used as determinants of tumor grade. Higher expression of CA19-9 in invasive front of SCC can be representative of local invasion and higher activity of tumor cells in the margins.
口腔鳞状细胞癌(OSCC)是全球最常见的癌症之一。原发性肿瘤的早期诊断是改善治疗效果的关键。基于分子标志物可进行癌症检测、预后判定以及疾病进展或治疗反应监测。CA19-9是一种分离形式的刘易斯抗原。它在临床中广泛用于检测胰腺癌。P57(KiP2)是一种肿瘤抑制基因。它是细胞增殖的正调节因子,通过抑制细胞周期蛋白依赖性激酶在G1期调节增殖。其表达在大多数恶性肿瘤中降低。OSCC具有不同的分化程度和局部侵袭潜能。
本研究旨在评估和分析CA19-9和P57表达与OSCC侵袭前沿及分级的相关性。
本横断面研究对40个石蜡块进行,这些石蜡块分为三种组织学分级;高分化、中分化和低分化鳞状细胞癌。通过免疫组织化学方法(En vision)评估这两种标志物。测量所有样本的比例和总分以及染色强度。
CA19-9在所有三个分级中的染色均较低。Kruskal Wallis检验显示肿瘤分级与CA19-9表达之间无显著相关性;然而,肿瘤强度与边缘强度之间存在显著差异(P = 0.003)。P57在所有三个分级中的染色均较高。Kruskal Wallis检验显示肿瘤分级与P57表达之间无显著相关性。肿瘤边缘的总染色强度无显著差异(P = 0.85)。
在本研究的局限性范围内,可以得出结论,CA19-9和P57的表达不能用作肿瘤分级的决定因素。CA19-9在SCC侵袭前沿的较高表达可代表局部侵袭以及边缘肿瘤细胞的较高活性。